DHEA risks
This article was originally published in The Tan Sheet
Executive Summary
Supplement may increase men's risk of prostate cancer, according to report in the August issue of Emergency Medicine. Marshall Goldberg, MD, Jefferson Medical College, says dehydroepiandrosterone (DHEA), increases the level of insulin-like growth factor-1 (IGF-1) in the bloodstream. Goldberg points to a study in the journal Science that found men with abnormally high levels of IGF-1 have a four- to seven-fold higher risk of prostate cancer. It is estimated over 1 mil. people take DHEA, which Goldberg notes "is unregulated and medically unsupervised"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning